Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase Ib of L-NMMA and Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GlucoCEST MRI in Oncology
- Status
- COMPLETED
- Phase
- NA
Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.
- Status
- UNKNOWN
- Phase
- PHASE4
Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Ruxolitinib in Operable Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
AVID100 in Advanced Epithelial Carcinomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immune Response Evaluation to Curative Conventional Therapy
- Status
- UNKNOWN
- Phase
- N/A
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).
- Status
- COMPLETED
- Phase
- PHASE1
Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC
- Status
- COMPLETED
- Phase
- NA